Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study.
- DOI
- 10.1007/s10147-025-02837-8
- Published
- 2025 Oct
- Container
- International journal of clinical oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10147-025-02837-8,
title = {Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study.},
author = {Morimoto K and Yamada T and Furuya N and Tanaka H and Yoshimura A and Oba T and Hibino M and Fukuda T and Goto Y and Nakao A and Ogusu S and Okazaki Y and Harada T and Ota T and Masubuchi K and Mikami K and Hata T and Matsumoto S and Honda R and Date K and Chihara Y and Takayama K},
year = {2025},
journal = {International journal of clinical oncology},
doi = {10.1007/s10147-025-02837-8},
url = {https://doi.org/10.1007/s10147-025-02837-8}
}RIS
TY - JOUR TI - Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study. AU - Morimoto K AU - Yamada T AU - Furuya N AU - Tanaka H AU - Yoshimura A AU - Oba T AU - Hibino M AU - Fukuda T AU - Goto Y AU - Nakao A AU - Ogusu S AU - Okazaki Y AU - Harada T AU - Ota T AU - Masubuchi K AU - Mikami K AU - Hata T AU - Matsumoto S AU - Honda R AU - Date K AU - Chihara Y AU - Takayama K PY - 2025 JO - International journal of clinical oncology DO - 10.1007/s10147-025-02837-8 UR - https://doi.org/10.1007/s10147-025-02837-8 ER -
APA
K, M., T, Y., N, F., H, T., A, Y., T, O., M, H., T, F., Y, G., A, N., S, O., Y, O., T, H., T, O., K, M., K, M., T, H., S, M., R, H., K, D., Y, C., & K, T. (2025). Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study.. International journal of clinical oncology. https://doi.org/10.1007/s10147-025-02837-8
Source records
- pubmed · retrieved 2026-09-26T00:32:30.695Z